Considering the serious clinical outcomes of ILD and the urgent need of diagnosis for ILD in RA patients [3], for the first time, our results showed that lectins of ConA, MNA-M, PHA-E could be candidate biomarkers for the diagnosis of RA-ILD. This evidence concerns the gene LBR and rheumatoid arthritis.